CCI
AERI

Columbus Circle Investors’s Aerie Pharmaceuticals AERI Stock Holding History

Columbus Circle Investors’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-598,830
Closed -$21.6M – 187
2018
Q4 		$21.6M Sell
598,830
-199,546
-25% -$9.36M 0.61% 73
2018
Q3 		$49.1M Buy
798,376
+24,196
+3% +$1.56M 0.98% 28
2018
Q2 		$52.3M Buy
774,180
+143,133
+23% +$8.01M 1.08% 23
2018
Q1 		$34.2M Buy
631,047
+37,961
+6% +$2.12M 0.69% 58
2017
Q4 		$35.4M Buy
593,086
+73,280
+14% +$4.44M 0.67% 53
2017
Q3 		$25.3M Buy
519,806
+151,133
+41% +$8.25M 0.43% 79
2017
Q2 		$19.4M Buy
368,673
+86,364
+31% +$4.02M 0.32% 86
2017
Q1 		$12.8M Buy
282,309
+48,689
+21% +$2.17M 0.18% 132
2016
Q4 		$8.84M Sell
233,620
-58,891
-20% -$2.23M 0.12% 158
2016
Q3 		$11M Buy
292,511
+217,365
+289% +$4.79M 0.12% 147
2016
Q2 		$1.32M Sell
75,146
-65,274
-46% -$1.06M 0.01% 222
2016
Q1 		$1.71M Buy
140,420
+77,963
+125% +$1.23M 0.02% 226
2015
Q4 		$1.52M Sell
62,457
-13,299
-18% -$310K 0.01% 246
2015
Q3 		$1.34M Sell
75,756
-288,623
-79% -$5.23M 0.01% 240
2015
Q2 		$6.43M Buy
364,379
+309,674
+566% +$5.68M 0.05% 232
2015
Q1 		$1.71M Sell
54,705
-31,227
-36% -$905K 0.01% 252
2014
Q4 		$2.51M Sell
85,932
-34,685
-29% -$880K 0.02% 242
2014
Q3 		$2.5M Buy
120,617
+72,588
+151% +$1.43M 0.02% 220
2014
Q2 		$1.19M Sell
48,029
-4,605
-9% -$79.8K 0.01% 259
2014
Q1 		$1.11M Buy
+52,634
New +$1.06M 0.01% 263

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Columbus Circle Investors's AERI Position: Q1 2019 in Review

Columbus Circle Investors sold out of Aerie Pharmaceuticals (AERI) in Q1 2019, closing a stake of 598,830 shares — an estimated $21.6M sold.

Columbus Circle Investors first reported a position in AERI in Q1 2014 and held it in 20 quarters. The position peaked at $52.3M in Q2 2018. 176 funds tracked by Wall St. Rank hold AERI as of Q1 2019.

  • Columbus Circle Investors reported no remaining Aerie Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Columbus Circle Investors sold 598,830 Aerie Pharmaceuticals shares in Q1 2019, an estimated $21.6M.
  • Columbus Circle Investors first reported a position in Aerie Pharmaceuticals in Q1 2014 and held it in 20 quarters.
  • Columbus Circle Investors's Aerie Pharmaceuticals position peaked at $52.3M in Q2 2018.
  • 176 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2019.

Based on Columbus Circle Investors's 13F filing for Q1 2019, filed 22 Apr 2019.